Thank you, Len. I'll start by providing a few more details on both the common equity capital raise that we completed on September 30th, and the subsequent balance sheet repositioning that was completed earlier this month. With respect to the capital raise, including the overallotment, we issued 4,999,050 common shares at a public offering price before underwriting discount and expenses of $25 per share. Net proceeds to the company were $118.6 million. On September 30th, we invested all of those net proceeds into the bank subsidiary in anticipation of the repositioning. Though the security sales themselves did not occur until after quarter end, our intent on September 30th was to liquidate a large portion of the portfolio, including certain securities classified as held to maturity. Accordingly, accounting rules require us to one, reclassify all securities previously classified as held to maturity to available for sale and two, recognize an earnings to the impairment related to the securities to be sold. Hence, the $140.4 million of impairment in the third quarter that drove the net loss for the period. Beginning October 1st, we commenced the balance sheet repositioning, which we completed on October 9th. Over that period, we sold $1 billion of securities, primarily corporates, munis and CMOs that had a book yield of 1.58%. Proceeds from the sales were used to pay in full our $418.7 million of Federal Reserve Bank term funding program borrowings, including accrued interest that were costing 4.77% and to purchase $590 million of Agency CMO and pass-through securities yielding 4.65%. We estimate the earnings breakeven period on the transaction is 4.5 years, which is well short of the 5.5 year weighted average life of the securities sold. The reinvestment mix focused on securities providing predictable, stable cash flow and earnings profiles, minimal credit risk and optimal liquidity. For reference, we include Slide 13 in the accompanying presentation materials to provide a before and after summary of our debt securities portfolio volume, mix, yield and duration. We expect the capital raise and balance sheet repositioning will immediately add about 70 basis points to our net interest margin and be about a $35 million boost to annualized net interest income. Transitioning to the balance sheet. Len covered the loan and deposit changes, so I'll touch on equity, which increased $19 million from June 30th, 2024, to $562.2 million, due primarily to the additional common stock and surplus from the capital raise, partially offset by a decrease in retained earnings driven by the securities impairment. The tangible common equity ratio was 7.22% on September 30th, 2024, up 34 basis points from June 30th, 2024, as tangible equity growth outpaced tangible asset growth. Turning to the income statement. On Slide 14, we reported a net loss of $95.7 million or $6.05 per common share. Adjusted earnings, which exclude net investment securities losses, mortgage servicing rights adjustment and merger-related costs were $9.1 million or $0.58 per common share. Net interest income increased $1.2 million in the third quarter to $37.5 million as compared to the linked-quarter, due primarily to higher earning asset yields and lower funding volumes partially offset by lower earning asset volumes and higher funding costs. Loan interest income in the third quarter of 2024 included $1.4 million of loan purchase discount accretion compared to $1.3 million in the linked-quarter. Our tax equivalent net interest margin increased 10 basis points to 2.51% in the third quarter compared to 2.41% in the linked-quarter as earning asset yields increased while funding costs were relatively flat. The average loan portfolio yield for the third quarter was 5.86%, a 17 basis point improvement from the linked-quarter, while the average yield on new loan originations during the third quarter were 7.58%. On the liability side, total deposit costs increased three basis points from the linked-quarter to 2.14%. Noninterest income in the third quarter of 2024 was a loss of $130.4 million due to the securities impairment. Adjusting for securities gains and losses, mortgage servicing right valuations and second quarter's gain on the Florida branch sales, noninterest income was up $600,000 from the linked-quarter due to improved quarter-over-quarter SBA gain on sale performance of $360,000 as well as a $200,000 BOLI death benefit recognized during the third quarter. Finishing with expenses. Total noninterest expense of $35.8 million in the third quarter was flat from the linked-quarter. Expenses in the third quarter included a $1.2 million fraud loss from a single incident and compared to linked-quarter, an additional $200,000 of costs related to foreclosed assets. Expense control remains a focus of our management team, and we continue to be pleased with our execution. And with that, I'll turn it back to the operator to open the line for questions.